Trevi Therapeutics, Inc. · NASDAQ:TRVI
Rosalind Advisors, Inc.'s stake in Trevi Therapeutics, Inc. fell to 1.20% (Schedule 13G/A)
Event Feb 13, 2025 · Filed Feb 13, 2025
Rosalind Advisors, Inc.'s stake in Trevi Therapeutics, Inc. fell to 1.20%, 1,062,500 shares, as a passive investor on Feb 13, 2025. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 1.20%
- Shares
- 1,062,500
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rosalind Advisors, Inc. | 1.20% | 1,062,500 |
| SALAMON STEVEN A J | 1.20% | 1,062,500 |
| Aharon Gil | 1.20% | 1,062,500 |
| Rosalind Master Fund L.P. | 1.20% | 1,062,500 |
Source
Related
- Trevi Therapeutics, Inc.
- Rosalind Advisors, Inc.
- Trevi Therapeutics, Inc. shareholders
- Form 4 · Heffernan Michael Thomas · Sep 17, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · May 7, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026